|
|
||||||||



*
Department of Comparative Physiology, Evolutionary Biology Centre, Uppsala University, Uppsala, Sweden;
Umeå Center for Molecular Pathogenesis, Umeå University, Umeå, Sweden; and
Department of Molecular Biology and Functional Genomics, Stockholm University, Stockholm, Sweden
| Abstract |
|---|
|
|
|---|
2 bacteria
per cell) also in the absence of added LPS. Gel shift experiment
suggests that the inhibitory effect is upstream or at the level of the
activation of the transcription factor Relish, a member of the
NF-
B/Rel family. The bacteria have to be in physical contact with
the cells, but not phagocytosed, to prevent LPS induction.
Interestingly, the inhibiting mechanism is, at least for E.
coli, independent of the type III secretion system, indicating
that the inhibitory mechanism is unrelated to the one earlier described
for YopJ from Yersinia. | Introduction |
|---|
|
|
|---|
-1,3 glucan, called pathogen-associated molecular
patterns (1). The fruitfly Drosophila
melanogaster produces at least seven distinct antimicrobial
peptides (cecropin, attacin, diptericin, insect defensin, drosocin,
drosomycin, and metchnikowin). The expression of the peptide genes is
in accordance with their antimicrobial effect; i.e., antifungal
peptides are more induced by fungi whereas antibacterial peptides are
more induced by bacteria (2, 3, 4). The promoters of all
seven genes contain
B sites, which are binding sites for
transcription factors of the NF-
B/Rel family. These factors are
dimers of Rel proteins and in mammals they play an important role in
the onset of an inflammatory response, this because they enhance
production of proteins like cytokines, acute phase response proteins,
and adhesion molecules (5). Dorsal, Dif, and Relish are
the known members of the Rel family in Drosophila. Relish
seems to be the Rel protein that contributes most to the expression of
antibacterial peptides (6) while both Relish and Dif play
a pivotal role during induction of antifungal peptides (4, 6, 7, 8). The recent findings that bacteria are able to counteract
induction of various host defenses (9, 10, 11, 12, 13) and that
antibacterial peptides efficiently kill bacteria (14)
prompted us to investigate whether bacteria counteract induction of
antimicrobial peptide genes. | Materials and Methods |
|---|
|
|
|---|
The Drosophila tumorous blood cell line mbn-2 was cultivated and infected essentially as previously described (15), although antibiotics were not used. The Salmonella typhimurium, Escherichia coli, Streptococcus equi, and Pseudomonas aeruginosa are clinical animal isolates obtained from the National Veterinary Institute (Uppsala, Sweden). Erwinia carotovora SCC3193 was a gift from M. Pirhonen (Swedish University of Agricultural Sciences, Uppsala, Sweden) and the Micrococcus luteus strain was provided by H. Boman (Karolinska Institute, Stockholm, Sweden). E. coli CVD 452, lacking an essential gene (sepB) for the type III secretion system, together with its parental strain E2348/69 were obtained from M. Donnenberg and J. Kaper (University of Maryland School of Medicine, Baltimore, MD). Bacteria were cultured in Luria-Bertani or tryptic soy broth at 37°C, except E. carotovora, which was cultured at 28°C.
Infection experiments
Bacterial overnight cultures were diluted 1/50 and cultivated to an OD600 of 0.5. One sample from each bacterial species was inactivated by incubating 10 ml of the culture in a 55°C (S. equi), 65°C (E. coli, S. typhimurium, and E. carotovora), or 70°C (M. luteus) waterbath for 15 min. After centrifugation, the bacterial cells were resuspended in Schneider medium and used for infecting the mbn-2 cells at a multiplicity of infection (MOI)3 of 20. In appropriate cases LPS (10 µg/ml, O127:B8, Sigma-Aldrich, St. Louis, MO) was added simultaneously with the bacteria to the mbn-2 cells. After 6 h of incubation, the mbn-2 cells were harvested and total RNA was extracted, using TRIzol reagent (Life Technologies, Rockville, MD). Northern blots were performed in accordance with standard protocols. The probes used were as follows: Diptericin cDNA (16), Cecropin A1 cDNA (17), Drosomycin cDNA (18), a PCR-generated probe (724 bp) for Drosocin based on published sequence (19), a PCR-generated probe (1396 bp) for GAPDH1 based on published sequence (20), a PCR-generated probe for ferritin (f-3TR) (21), and a PCR-generated probe for rp49 (22), the latter probe was used as a loading control.
EMSA
The mbn-2 cells were infected as described above and nuclear
extracts were prepared as previously described (23). The
protein concentration in the nuclear extracts was determined by the
Bradford assay. Binding reactions were conducted by mixing 0.5 ng of a
32P-labeled probe
(5'-GTGACATCGGGGATTCCTTTTGCAA), containing a
B site present in
the Diptericin promoter (24), 10 µg of
nuclear extract, 60 µg BSA, and 1 µg of poly(dI-dC) in 20 µl of a
buffer containing 20 mM HEPES, 100 mM NaCl, 1 mM EDTA, and 8.5% (v/v)
glycerol. A Relish Ab (25) was in appropriate cases added
to the nuclear extracts immediately before addition of the
B probe.
After 15 min, incubation at room temperature EMSA was conducted as
described elsewhere (26).
Experiments using transwells and cytochalasin D
Infection of mbn-2 cells was essentially conducted as described
above. Transwells (Costar, Cambridge, MA) were used; these have a
permeable (0.4 µm) membrane situated close to the bottom of the well
preventing added bacteria from coming in direct contact with the mbn-2
cells seeded below the membrane (see Fig. 5
B). Cytochalasin
D (5 µM, Sigma-Aldrich), dissolved in DMSO, was added 30 min before
bacterial infection to prevent phagocytosis. The final concentration of
DMSO in the wells was 2.5 µl/ml. That cytochalasin D inhibited
phagocytosis was controlled microscopically using FITC-labeled
heat-inactivated E. coli.
|
mbn-2 cells were infected with live E. coli (MOI 20) and 10 µg/ml LPS and after 2 h of incubation, the cells were washed with 1x PBS-D and resuspended in growth medium containing 10 µg/ml LPS, 200 µg/ml gentamicin, and 200 µg/ml streptomycin. Northern blot was performed after incubation for the times indicated. Gentamicin and streptomycin were controlled not to induce Diptericin by themselves.
| Results |
|---|
|
|
|---|
Six bacterial species were tested for their ability to counteract
LPS induction of four antimicrobial peptide genes, using the
Drosophila blood cell-line mbn-2 (Fig. 1
). Beside S. equi, all
heat-inactivated bacteria strongly induced the three antibacterial
peptide genes Diptericin, Drosocin, and
Cecropin A1 while Drosomycin, an antifungal
peptide gene, was less induced. That neither live nor dead S.
equi induced any antimicrobial peptide gene is noteworthy because
this bacterium normally gives rise to a strong inflammatory response in
mammals (27). Live E. coli, S.
typhimurium, E. carotovora, and P.
aeruginosa did not induce any of the four antimicrobial peptide
genes tested. Interestingly, although LPS is a strong elicitor of
antimicrobial peptide genes, no induction of the antimicrobial peptide
genes occurred when LPS was added together with any of the four enteric
bacteria to the mbn-2 cells (Fig. 1
). This suggests that these bacteria
secrete a component that block the signal transduction pathway,
initiated by the recognition of LPS and culminating in enhanced
expression of antimicrobial peptide genes. It seems that the tested
enteric bacteria have less ability to inhibit induction of
Cecropin compared with the other antimicrobial peptides and
that this phenomenon is more pronounced for Pseudomonas
(Fig. 1
). To test whether any serum component affected the obtained
results we exchanged the serum-containing growth medium to Ultimate
Insect Serum-Free medium (Invitrogen, San Diego, CA). The obtained
results were identical for the two growth media.
|
To investigate the mechanism that counteracts LPS induction of
antimicrobial peptide genes we focused on E. coli and the
antibacterial peptide gene Diptericin. EMSA experiments were
performed to elucidate whether the E. coli component
counteracts activation of Rel proteins. LPS and heat-inactivated
E. coli strongly activated Rel proteins with affinity to a
B site present in the Diptericin promoter whereas live
E. coli or LPS plus live E. coli did not activate
Rel proteins (Fig. 2
). A Relish-specific
Ab shifted the whole single band displayed, indicating that Relish
constitutes at least one part of the dimer that forms a complex with
the
B-probe (Fig. 2
).
|
Time studies showed that live E. coli immediately
starts to suppress LPS induction of Diptericin and that the
induction is suppressed during the whole incubation (Fig. 3
). How different bacterial
concentrations affected the inhibitory effect on LPS induction was also
tested and as seen in Fig. 4
the
inhibitory effect disappears when the bacterial inoculum is lowered to
107 CFU, corresponding to a MOI of 2 bacteria per
cell. When the experiments in Fig. 4
were repeated without adding free
LPS to the wells we found that 107,
106, and 105 CFU of live
E. coli strongly induced Diptericin while
108 CFU did not (data not shown). Thus, the
innate immune system recognizes live E. coli, but at a MOI
of 20 and higher the bacterial inhibitory effect suppress the induction
of Diptericin.
|
|
Blocking phagocytosis by addition of cytochalasin D and inhibiting
direct physical contact between bacteria and cells by a membrane showed
that the bacterium has to be in physical contact with the host cell but
not necessarily phagocytosed to prevent LPS induction of
Diptericin (Fig. 5
, A and B). These results suggested that the
E. coli inhibitory factor is secreted by a type III
secretion system. Many pathogenic Gram-negative bacteria, including the
four species in this study, use a type III secretion system to
translocate proteins directly into the cytosol of host cells
(28). Once inside the host cell, the bacterial proteins
start to manipulate the host cell in a way that is beneficial for the
bacterium. However, an E. coli mutant, CVD 452, lacking an
essential gene for the type III secretion system was found to inhibit
LPS induction of Diptericin as much as its parental strain
2348/69 (Fig. 5
C). In addition the transwell experiment
shows that the bacterial inhibitory effect is not due to changes in the
medium caused by active microbial metabolism or oxygen depletion
because infection with 109 CFU of live E.
coli did not show any significant reduction in the inducibility of
Diptericin (Fig. 5
B).
The inhibitory effect on LPS induction is specific and reversible
Northern blot experiments showed that transcription from nonimmune
genes was unaffected by live E. coli (Fig. 6
). This shows that E. coli
does not generally increase the mRNA turnover but specifically
counteract LPS induction. Furthermore, we investigated whether the
E. coli inhibitory effect is reversible. mbn-2 cells were
infected with LPS and live E. coli and after 2 h of
incubation the wells were washed once to reduce the number of bacteria.
The cells were further incubated with fresh medium containing LPS and
antibiotics. Northern blot showed that E. coli-infected
cells had induced Diptericin 2 h postwashing (Fig. 7
). Thus, the inhibitory effect is
reversible and cells expressing antimicrobial peptide genes are not
killed by E. coli.
|
|
| Discussion |
|---|
|
|
|---|
, and thereby is phosphorylation of I-
B, a step in
activation of NF-
B blocked (12). That the bacterial
mechanism suppressing LPS induction described here is similar to the
one in Yersinia is unlikely because no type III secretion
system is required for E. coli. Recently, it was shown that
nonpathogenic Salmonella (S. Pullorum) is capable
of attenuating the IL-8 secretion characteristically elicited by
TNF-
and pathogenic S. typhimurium (13). The
inhibitory effect was also in this case achieved by inhibiting
activation of NF-
B. However, inhibition of NF-
B activation is in
this case not reached by blocking phosphorylation of I-
B but by
inhibiting the subsequent step, namely polyubiquitination of I-
B
(9). Whether the anti-inflammatory mechanism of
S. Pullorum is related to the one here described for enteric
bacteria is today an open question. Like mammals, insects possess a circulatory system and a complex innate immune response. Recent data have shown that pathogen recognition, signaling pathways, and effector mechanisms of innate immunity are conserved between Drosophila and mammals (29). Our finding that enteric bacteria normally present in mammals suppress the immune system in an insect show that also the interplay between enteric bacteria and the innate immune system is evolutionary conserved. Taken together, this suggests that Drosophila is a useful model for studying how microbes interact with the innate immune system of higher organisms.
We thank J. Kaper and M. S. Donnenberg for the E. coli strains.
| Footnotes |
|---|
2 Address correspondence and reprint requests to Dr. Kenneth Söderhäll, Department of Comparative Physiology, Evolutionary Biology Centre, Uppsala University, Norbyvägen 18A, SE-752 36 Uppsala, Sweeden. E-mail address: kenneth.soderhall{at}ebc.uu.se ![]()
3 Abbreviation used in this paper: MOI, multiplicity of infection. ![]()
Received for publication July 9, 2001. Accepted for publication October 18, 2001.
| References |
|---|
|
|
|---|
B and Rel proteins: evolutionary conserved mediators of immune responses. Annu. Rev. Immunol. 16:225.[Medline]
B factor. Genes Dev. 13:792.
B-
ubiquitination. Science 289:1560.
B factor Relish by rapid endoproteolytic cleavage. EMBO Rep. 1:347.[Medline]
This article has been cited by other articles:
![]() |
L. LAMBRECHTS, I. MORLAIS, P. H. AWONO-AMBENE, A. COHUET, F. SIMARD, J.-C. JACQUES, C. BOURGOUIN, and J. C. KOELLA EFFECT OF INFECTION BY PLASMODIUM FALCIPARUM ON THE MELANIZATION IMMUNE RESPONSE OF ANOPHELES GAMBIAE Am J Trop Med Hyg, March 1, 2007; 76(3): 475 - 480. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Bulmer and R. H. Crozier Variation in Positive Selection in Termite GNBPs and Relish Mol. Biol. Evol., February 1, 2006; 23(2): 317 - 326. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. W. Shin, V. Kokoza, G. Bian, H.-M. Cheon, Y. J. Kim, and A. S. Raikhel REL1, a Homologue of Drosophila Dorsal, Regulates Toll Antifungal Immune Pathway in the Female Mosquito Aedes aegypti J. Biol. Chem., April 22, 2005; 280(16): 16499 - 16507. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. P. Lazzaro Elevated Polymorphism and Divergence in the Class C Scavenger Receptors of Drosophila melanogaster and D. simulans Genetics, April 1, 2005; 169(4): 2023 - 2034. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |